A detailed history of Robeco Institutional Asset Management B.V. transactions in Alkermes Plc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 95,509 shares of ALKS stock, worth $2.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
95,509
Previous 49,652 92.36%
Holding current value
$2.75 Million
Previous $1.2 Million 123.49%
% of portfolio
0.01%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$23.01 - $28.55 $1.06 Million - $1.31 Million
45,857 Added 92.36%
95,509 $2.67 Million
Q2 2024

Jul 22, 2024

BUY
$23.21 - $27.24 $225,949 - $265,181
9,735 Added 24.39%
49,652 $1.2 Million
Q1 2024

Apr 24, 2024

BUY
$26.4 - $32.56 $45,592 - $56,231
1,727 Added 4.52%
39,917 $1.08 Million
Q4 2023

Feb 14, 2024

BUY
$23.37 - $28.68 $16,989 - $20,850
727 Added 1.94%
38,190 $1.06 Million
Q4 2023

Feb 08, 2024

BUY
$23.37 - $28.68 $552,957 - $678,597
23,661 Added 171.43%
37,463 $38.2 Million
Q3 2023

Oct 23, 2023

BUY
$27.17 - $31.97 $375,000 - $441,249
13,802 New
13,802 $386,000
Q2 2022

Jul 27, 2022

SELL
$26.4 - $30.54 $191,268 - $221,262
-7,245 Closed
0 $0
Q1 2022

Dec 01, 2022

SELL
$23.07 - $27.99 $795,153 - $964,731
-34,467 Reduced 82.63%
7,245 $191,000
Q1 2022

Apr 26, 2022

SELL
$23.07 - $27.99 $795,153 - $964,731
-34,467 Reduced 82.63%
7,245 $191,000
Q4 2021

Dec 01, 2022

BUY
$21.47 - $32.08 $895,556 - $1.34 Million
41,712 New
41,712 $971,000
Q4 2021

Jan 31, 2022

BUY
$21.47 - $32.08 $895,556 - $1.34 Million
41,712 New
41,712 $971,000
Q3 2019

Oct 17, 2019

SELL
$19.51 - $24.28 $73,923 - $91,996
-3,789 Closed
0 $0
Q2 2019

Jul 19, 2019

SELL
$21.47 - $37.33 $21,534 - $37,441
-1,003 Reduced 20.93%
3,789 $86,000
Q4 2017

Jan 25, 2018

BUY
$47.69 - $55.39 $132,864 - $154,316
2,786 Added 138.88%
4,792 $262,000
Q1 2017

Jan 19, 2021

BUY
N/A
2,006
2,006 $118,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.